Evidence map›Paper›PMID 26768269›Full record

ArticleObesity surgery2016

Treatment Discontinuation Following Bariatric Surgery in Obstructive Sleep Apnea: a Controlled Cohort Study.

Claire Agosta, Jean-Christian Borel, Fabian Reche, Catherine Arvieux, Nelly Wion, Samir Jaber, Dany Jaffuel, Jean-Louis Pépin, Anne-Laure Borel

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Claire AgostaPole DIGIDUNE, Endocrinology Department, Grenoble University Hospital, Grenoble, France.
Jean-Christian Borel"ICàdom", Agiràdom, Meylan, France.
Fabian RechePole DIGIDUNE, Digestive Surgery Department, Grenoble University Hospital, Grenoble, France.
Catherine ArvieuxPole DIGIDUNE, Digestive Surgery Department, Grenoble University Hospital, Grenoble, France.
Nelly Wion"ICàdom", Agiràdom, Meylan, France.
Samir JaberAnaesthesiology and Intensive Care, Anaesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, INSERM U1046, Montpellier 1 University, Montpellier University Hospital, Montpellier, 34295, France.
Dany JaffuelPulmonary Disorders and Respiratory Sleep Disorders Unit, Polyclinic Saint-Privat, 34760, Boujan sur Libron, France.
Jean-Louis PépinHP2 laboratory, INSERM U1042, Grenoble Alpes University, Grenoble, France.
Anne-Laure BorelPole DIGIDUNE, Endocrinology Department, Grenoble University Hospital, Grenoble, France. alborel@chu-grenoble.fr.
Université Grenoble Alpes · FRCentre Hospitalier Universitaire de Grenoble · FRInserm · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUncontrolled studies looking at the discontinuation of obstructive sleep apnea (OSA) treatment after bariatric surgery (BS) have suggested that surgery improves OSA. However, this discontinuation of OSA treatment by BS patients has never been compared to a matched population without BS. The objectives of this study are to evaluate whether BS increases OSA treatment discontinuation compared to that in matched patients without BS and to identify predictive factors of OSA treatment discontinuation in BS patients. The study took place in an ambulatory, tertiary hospital.

methodsWe included 61 OSA patients who underwent BS in a retrospective controlled cohort study. The computerized matching procedure included age, sex, body mass index, year of starting OSA treatment, treatment type, and duration selected 59 controls matched to 28 patients with BS. The main outcome was OSA treatment discontinuation within 2 years after BS.

resultsPatients with BS stopped OSA treatment more often than controls, usually between 6 months and 1 year after BS: hazards ratio (HR (95 %, CI)) 15.93 (3.29, 77.00). Before 6 months or beyond 1 year after BS, treatment discontinuation was not different between BS patients and controls. In univariate analyses, female gender, absence of co-morbidities, greater weight loss, and lower baseline OSA severity were associated with stopping OSA treatment after BS. No factor remained independently associated in multivariate analysis.

conclusionsApneic patients having BS stop OSA treatment more than matched controls. Treatment discontinuation may be attributed to recovery or to abandonment. The effect of BS on OSA may have been overestimated in uncontrolled BS studies that ignored basal OSA treatment discontinuation in routine clinical practice.

Indexed as

Patient ComplianceAdultBariatric SurgeryCase-Control StudiesCohort StudiesComorbidityFemaleFranceHumansMaleMiddle AgedObesity, MorbidPolysomnographyRetrospective StudiesSleep Apnea, ObstructiveBariatric surgeryCohortContinuous positive airway pressureControlledSleep apnea syndrome

Identifiers

PMID26768269
OpenAlexW2249322904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.